As 2019 comes to an end, we reflect on a year of hope and growth, with immense gratitude for our community. In 2020 we will continue to focus on helping people with...
Time in Range News
Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.
22 readers recommended
New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2...
15 readers recommended
En el Mes Nacional de la Salud de las Minorías, el autor comparte la historia de su diagnóstico de diabetes tipo 2
23 readers recommended
In-person visits, lab tests, and finger stick documentation are no longer required at present to get a CGM
34 readers recommended
Major milestones in 2019 brought time in range to the forefront of diabetes care
19 readers recommended
The diaTribe team was on the ground in Madrid, Spain to cover the latest news in diabetes technology from ATTD. Here are our top highlights from the conference!
23 readers recommended
The ADA Scientific Sessions starts later this week – we've highlighted some of the most important presentations and posters for you to look forward to
23 readers recommended
In exciting news, Tandem announced expanded clearance for the hybrid closed loop Control-IQ. The system is now available for children ages 6-13
26 readers recommended
The Time in Range Coalition aims to help millions of people by promoting time in range in diabetes care
23 readers recommended
The G6 Pro includes several exciting new features and is expected to start shipping next week!
17 readers recommended
Mark Harmel, MPH, CDCES, discusses how his clinic is moving to telemedicine in the time of COVID-19 and how to share data from many diabetes devices
21 readers recommended
dQ&A surveyed 2,540 CGM users with type 1 or type 2 diabetes to find out how aware they are of their own time in range: 87% of respondents knew how much time they...
17 readers recommended
Dr. Anne Peters shares insights on how healthcare professionals can help people ease the challenges of managing diabetes during COVID and how the shift to telemedicine...
22 readers recommended
We interviewed Dr. Partha Kar to learn about how people are using time in range in his clinic and what obstacles our society will need to overcome to promote wider use...
24 readers recommended
Rybelsus, a GLP-1 agonist pill already approved in Europe and the US, has just been approved by Health Canada for adults with type 2 diabetes
22 readers recommended
Health Canada authorizes the latest temporary approval for CGM during the pandemic: the Dexcom G6 is now available to pregnant women with diabetes
26 readers recommended
Expert physicians share a few of the benefits of virtual appointments for people living with diabetes
24 readers recommended
Enroll in Level2 to get a CGM, a Fitbit activity tracker, and easily accessible virtual health coaching; the program is designed to help people achieve type 2 diabetes...
29 readers recommended
Dive into AGP if you haven’t already! In our third video on understanding your ambulatory glucose profile (AGP) report, Dr. Carlson from the International Diabetes...
29 readers recommended
Though A1C has long been used as the primary metric for evaluating someone’s estimated average blood sugar, the glucose management indicator (GMI) is an alternative that...